A detailed history of Mediolanum International Funds LTD transactions in Biogen Inc. stock. As of the latest transaction made, Mediolanum International Funds LTD holds 4,893 shares of BIIB stock, worth $850,354. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,893
Previous 5,134 4.69%
Holding current value
$850,354
Previous $1.1 Billion 13.25%
% of portfolio
0.01%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$189.07 - $236.8 $45,565 - $57,068
-241 Reduced 4.69%
4,893 $951 Million
Q2 2024

Aug 13, 2024

SELL
$190.52 - $236.72 $4.79 Million - $5.95 Million
-25,144 Reduced 83.04%
5,134 $1.1 Billion
Q1 2024

May 03, 2024

BUY
$212.02 - $267.71 $6.42 Million - $8.11 Million
30,278 New
30,278 $6.55 Billion

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Mediolanum International Funds LTD Portfolio

Follow Mediolanum International Funds LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mediolanum International Funds LTD, based on Form 13F filings with the SEC.

News

Stay updated on Mediolanum International Funds LTD with notifications on news.